Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q2 2024 to Q3 2024
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 3
- Est. +$859.2K
- Added
- 20
- Est. +$1.01M
- Reduced
- 42
- Est. −$11.2M
- Sold out
- 4
- Est. −$871.5K
Portfolio value went from $208.9M to $212.0M (+$3.12M (+1.5%)); positions from 68 to 67 (−1).
All Q3 2024 holdingsAll Q2 2024 holdings
In the shares, value and % of portfolio columns, the top figure is Q3 2024 and the gray one below is Q2 2024. For stocks that split between the two quarters, Q2 2024 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| ANNXAnnexon, Inc. | ReducedHistory | 10,48316,103 | −5,620−34.9% | $62.1K$78.9K | −$33.3K | <0.1%<0.1% | −0.01 |
| CTMXCytomX Therapeutics, Inc. | ReducedHistory | 59,76064,065 | −4,305−6.7% | $70.5K$78.2K | −$5.08K | <0.1%<0.1% | 0.00 |
| PSTXPoseida Therapeutics, Inc. | ReducedHistory | 27,85529,817 | −1,962−6.6% | $79.7K$87.1K | −$5.61K | <0.1%<0.1% | 0.00 |
| GERNGeron Corp | ReducedHistory | 18,49119,906 | −1,415−7.1% | $83.9K$84.4K | −$6.42K | <0.1%<0.1% | 0.00 |
| KRONKronos Bio, Inc. | ReducedHistory | 90,998134,998 | −44,000−32.6% | $91.0K$167.4K | −$44.0K | <0.1%0.1% | −0.04 |
| COGTCogent Biosciences, Inc. | ReducedHistory | 10,02115,627 | −5,606−35.9% | $108.2K$131.7K | −$60.5K | 0.1%0.1% | −0.01 |
| ZURAZura Bio Ltd | ReducedHistory | 30,81041,569 | −10,759−25.9% | $125.1K$145.5K | −$43.7K | 0.1%0.1% | −0.01 |
| IMTXImmatics N.V. | ReducedHistory | 11,18011,987 | −807−6.7% | $127.6K$139.3K | −$9.21K | 0.1%0.1% | −0.01 |
| MREOMereo BioPharma Group plc | ReducedHistory | 33,80036,231 | −2,431−6.7% | $138.9K$130.4K | −$9.99K | 0.1%0.1% | 0.00 |
| iShares Tr464288513 | Reduced– | 2,8894,975 | −2,086−41.9% | $232.1K$383.8K | −$167.6K | 0.1%0.2% | −0.07 |
| TMOThermo Fisher Scientific Inc. | ReducedHistory | 430456 | −26−5.7% | $266.7K$253.3K | −$16.1K | 0.1%0.1% | 0.00 |
| REGNRegeneron Pharmaceuticals, Inc. | ReducedHistory | 297328 | −31−9.5% | $312.2K$344.7K | −$32.6K | 0.1%0.2% | −0.02 |
| Tidal ETF Tr886364603 | Reduced– | 16,16116,399 | −238−1.5% | $333.1K$313.3K | −$4.91K | 0.2%0.1% | +0.01 |
| INCYIncyte Corp | ReducedHistory | 5,7476,158 | −411−6.7% | $379.9K$373.3K | −$27.2K | 0.2%0.2% | 0.00 |
| Vanguard Emerging Markets Government Bond ETF921946885 | Reduced– | 5,7768,034 | −2,258−28.1% | $383.3K$505.4K | −$149.9K | 0.2%0.2% | −0.06 |
| PFEPfizer Inc | ReducedHistory | 14,29415,049 | −755−5.0% | $413.6K$421.1K | −$21.8K | 0.2%0.2% | −0.01 |
| UNHUnitedHealth Group Inc | ReducedHistory | 733877 | −144−16.4% | $430.8K$448.9K | −$84.6K | 0.2%0.2% | −0.01 |
| DEDeere & Co | ReducedHistory | 1,1142,218 | −1,104−49.8% | $464.9K$829.0K | −$460.8K | 0.2%0.4% | −0.18 |
| iShares Tr464287432 | Reduced– | 5,0355,874 | −839−14.3% | $493.9K$539.2K | −$82.3K | 0.2%0.3% | −0.03 |
| Invesco Exch TRD SLF Idx FD46138J460 | Reduced– | 35,99842,739 | −6,741−15.8% | $610.2K$694.9K | −$114.3K | 0.3%0.3% | −0.04 |
| iShares Tr46429B655 | Reduced– | 12,18921,697 | −9,508−43.8% | $622.1K$1.11M | −$485.3K | 0.3%0.5% | −0.24 |
| JPMJPMorgan Chase & Co | ReducedHistory | 3,2816,516 | −3,235−49.6% | $691.8K$1.32M | −$682.1K | 0.3%0.6% | −0.30 |
| iShares Tr464288661 | Reduced– | 10,76611,884 | −1,118−9.4% | $1.29M$1.37M | −$133.7K | 0.6%0.7% | −0.05 |
| WisdomTree Tr97717W562 | Reduced– | 26,05230,424 | −4,372−14.4% | $1.37M$1.43M | −$230.6K | 0.6%0.7% | −0.04 |
| iShares Tr464287440 | Reduced– | 14,15015,430 | −1,280−8.3% | $1.39M$1.45M | −$125.6K | 0.7%0.7% | −0.04 |
| Vanguard Morningstar Value ETF922908744 | Reduced– | 8,0698,114 | −45−0.6% | $1.41M$1.30M | −$7.86K | 0.7%0.6% | +0.04 |
| iShares Tr46429B747 | Reduced– | 16,38922,030 | −5,641−25.6% | $1.66M$2.19M | −$571.5K | 0.8%1.0% | −0.27 |
| iShares Inc46434G509 | Reduced– | 62,80663,610 | −804−1.3% | $1.78M$1.72M | −$22.9K | 0.8%0.8% | +0.02 |
| NVDANVIDIA Corp | ReducedHistory | 15,55731,098 | −15,541−50.0% | $1.89M$3.84M | −$1.89M | 0.9%1.8% | −0.95 |
| SPDR Series Trust78468R200 | Reduced– | 64,83766,243 | −1,406−2.1% | $2.00M$2.04M | −$43.4K | 0.9%1.0% | −0.03 |
| iShares Tips Bond ETF464287176 | Reduced– | 19,07721,531 | −2,454−11.4% | $2.11M$2.30M | −$271.1K | 1.0%1.1% | −0.11 |
| Vanguard Intl Equity Index F922042676 | Reduced– | 52,94154,159 | −1,218−2.2% | $2.48M$2.20M | −$57.1K | 1.2%1.1% | +0.12 |
| iShares Core High Dividend ETF46429B663 | Reduced– | 45,61548,558 | −2,943−6.1% | $5.37M$5.28M | −$346.2K | 2.5%2.5% | 0.00 |
| iShares Tr464288372 | Reduced– | 102,789109,701 | −6,912−6.3% | $5.59M$5.26M | −$376.2K | 2.6%2.5% | +0.12 |
| iShares Tr464288588 | Reduced– | 59,61561,210 | −1,595−2.6% | $5.71M$5.62M | −$152.8K | 2.7%2.7% | 0.00 |
| Invesco Exch Traded FD Tr II46138G508 | Reduced– | 280,587287,819 | −7,232−2.5% | $5.90M$6.06M | −$151.9K | 2.8%2.9% | −0.12 |
| DBX ETF Tr233051200 | Reduced– | 148,602184,116 | −35,514−19.3% | $6.24M$7.63M | −$1.49M | 2.9%3.7% | −0.71 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Reduced– | 33,71235,342 | −1,630−4.6% | $6.84M$6.89M | −$330.5K | 3.2%3.3% | −0.07 |
| DJPBarclays Bank PLC | ReducedHistory | 226,009232,047 | −6,038−2.6% | $7.29M$7.44M | −$194.7K | 3.4%3.6% | −0.12 |
| First Tr Exchange-Traded FD33738D101 | Reduced– | 220,033232,768 | −12,735−5.5% | $7.39M$7.09M | −$427.9K | 3.5%3.4% | +0.09 |
| PIMCO ETF Tr72201R304 | Reduced– | 202,248209,072 | −6,824−3.3% | $11.7M$11.3M | −$394.1K | 5.5%5.4% | +0.10 |
| Vanguard Ftse Emerging Markets ETF922042858 | Reduced– | 295,537325,358 | −29,821−9.2% | $14.1M$14.2M | −$1.43M | 6.7%6.8% | −0.15 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.